| Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management AU Anka, MI Tahir, SD Abubakar, M Alsabbagh, Z Zian, H Hamedifar, ... Scandinavian journal of immunology 93 (4), e12998, 2021 | 341 | 2021 |
| The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer A Masjedi, V Hashemi, M Hojjat-Farsangi, G Ghalamfarsa, G Azizi, ... Biomedicine & Pharmacotherapy 108, 1415-1424, 2018 | 264 | 2018 |
| Selective IgA deficiency: epidemiology, pathogenesis, clinical phenotype, diagnosis, prognosis and management R Yazdani, G Azizi, H Abolhassani, A Aghamohammadi Scandinavian journal of immunology 85 (1), 3-12, 2017 | 222 | 2017 |
| The paradox of Th17 cell functions in tumor immunity Z Asadzadeh, H Mohammadi, E Safarzadeh, M Hemmatzadeh, ... Cellular immunology 322, 15-25, 2017 | 211 | 2017 |
| Primary immunodeficiency and autoimmunity: a comprehensive review L Amaya-Uribe, M Rojas, G Azizi, JM Anaya, ME Gershwin Journal of autoimmunity 99, 52-72, 2019 | 200 | 2019 |
| Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis G Azizi, F Jadidi‐Niaragh, A Mirshafiey International journal of rheumatic diseases 16 (3), 243-253, 2013 | 162 | 2013 |
| A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders AN Kamali, SM Noorbakhsh, H Hamedifar, F Jadidi-Niaragh, R Yazdani, ... Molecular immunology 105, 107-115, 2019 | 159 | 2019 |
| Common variable immunodeficiency: epidemiology, pathogenesis, clinical manifestations, diagnosis, classification, and management. R Yazdani, S Habibi, L Sharifi, G Azizi, H Abolhassani, P Olbrich, ... Journal of investigational allergology & clinical immunology 30 (1), 14-34, 2019 | 147 | 2019 |
| CD73 as a potential opportunity for cancer immunotherapy G Ghalamfarsa, MH Kazemi, S Raoofi Mohseni, A Masjedi, ... Expert opinion on therapeutic targets 23 (2), 127-142, 2019 | 129 | 2019 |
| Clinical, immunological, and genetic features in patients with activated PI3Kδ syndrome (APDS): a systematic review M Jamee, S Moniri, M Zaki-Dizaji, P Olbrich, R Yazdani, F Jadidi-Niaragh, ... Clinical Reviews in Allergy & Immunology 59, 323-333, 2020 | 118 | 2020 |
| Fourth update on the Iranian National Registry of Primary Immunodeficiencies: integration of molecular diagnosis H Abolhassani, F Kiaee, M Tavakol, Z Chavoshzadeh, SA Mahdaviani, ... Journal of clinical immunology 38, 816-832, 2018 | 117 | 2018 |
| The role of different subsets of regulatory T cells in immunopathogenesis of rheumatoid arthritis M Gol-Ara, F Jadidi-Niaragh, R Sadria, G Azizi, A Mirshafiey Arthritis 2012, 2012 | 114 | 2012 |
| Autoimmunity in common variable immunodeficiency: epidemiology, pathophysiology and management G Azizi, H Abolhassani, MH Asgardoon, T Alinia, R Yazdani, ... Expert review of clinical immunology 13 (2), 101-115, 2017 | 110 | 2017 |
| Global systematic review of primary immunodeficiency registries H Abolhassani, G Azizi, L Sharifi, R Yazdani, M Mohsenzadegan, ... Expert review of clinical immunology 16 (7), 717-732, 2020 | 108 | 2020 |
| The effects of cadmium exposure in the induction of inflammation N Hossein-Khannazer, G Azizi, S Eslami, H Alhassan Mohammed, ... Immunopharmacology and immunotoxicology 42 (1), 1-8, 2020 | 105 | 2020 |
| Clinical, immunologic, and molecular spectrum of patients with LPS-responsive beige-like anchor protein deficiency: a systematic review S Habibi, M Zaki-Dizaji, H Rafiemanesh, B Lo, M Jamee, L Gámez-Díaz, ... The Journal of Allergy and Clinical Immunology: in Practice 7 (7), 2379-2386. e5, 2019 | 97 | 2019 |
| Clinical, immunologic, and genetic spectrum of 696 patients with combined immunodeficiency H Abolhassani, J Chou, W Bainter, CD Platt, M Tavassoli, T Momen, ... Journal of Allergy and Clinical Immunology 141 (4), 1450-1458, 2018 | 97 | 2018 |
| Infectious and noninfectious pulmonary complications in patients with primary immunodeficiency disorders. R Yazdani, H Abolhassani, MH Asgardoon, M Shaghaghi, M Modaresi, ... Journal of investigational allergology & clinical immunology 27 (4), 213-224, 2017 | 95 | 2017 |
| Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer V Karpisheh, A Nikkhoo, M Hojjat-Farsangi, A Namdar, G Azizi, ... Prostaglandins & other lipid mediators 144, 106338, 2019 | 94 | 2019 |
| The hyper IgM syndromes: Epidemiology, pathogenesis, clinical manifestations, diagnosis and management R Yazdani, S Fekrvand, S Shahkarami, G Azizi, B Moazzami, ... Clinical Immunology 198, 19-30, 2019 | 89 | 2019 |
